Real-life dosing with second-generation antipsychotics.
Correll
Christoph U
CU
The Zucker Hillside Hospital, 75-59 263rd Street, Glen Oaks, NY 11004, USA.
D014150:Antipsychotic Agents / Q000008:administration & dosage* / Q000493:pharmacokinetics / Q000627:therapeutic use; D017327:Clinical Trials, Phase IV as Topic; D004334:Drug Administration Schedule; D017277:Drug Approval; D006801:Humans; D020714:Maximum Tolerated Dose; D011358:Product Surveillance, Postmarketing; D011618:Psychotic Disorders / Q000188:drug therapy*; D016032:Randomized Controlled Trials as Topic; D012559:Schizophrenia / Q000188:drug therapy; D012565:Schizophrenic Psychology; D016896:Treatment Outcome; D014481:United States; D014486:United States Food and Drug Administration
D014150:Antipsychotic Agents